HAL (France)open access
Hemoglobin A1c Reduction With the GLP-1 Receptor Agonist Semaglutide Is Independent of Baseline eGFR: post hoc Analysis of the SUSTAIN and PIONEER Programs
1, Chronic kidney disease, Diabetes, 0
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 185341
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.